The highly reactive 1:1 intermediate produced in the reaction between tert-butyl isocyanide and dialkyl acetylenedicarboxylates is trapped by dialkyl 2-bromomalonates to yield the title compounds in fairly high yields.2H-Pyran-2-one and its derivatives are important starting materials in the synthesis of cyclobutadienes. 1Y2 These heterocycles ¢nd use in cycloaddition reactions, providing bicyclolactone adducts which can be elaborated into a variety of highly functionalized cyclohexadienes and benzenes. 3À5 Current synthetic methodology for preparation of this class of compounds still remains fairly speci¢c. 6Y7 Here, a direct, e¤cient and operationally convenient approach to the synthesis of highly functionalized 2H-pyran-2-one derivatives 3 using dialkyl 2-bromomalonates 2 is presented. Thus, reaction of tert-butyl isocyanide with dialkyl acetylenedicarboxylates 1 in the presence of a strong CH-acid such as 2 leads to the corresponding 2H-pyran-2-one derivatives 3 (Scheme 1).The three-component condensation reactions produce the hitherto unknown functionalized 2H-pyran-2-ones 3 in high yields. The structures of the isolated crystalline compounds 3a ^d were deduced from elemental analyses, 1 H and 13 C NMR spectroscopy. IR spectroscopy was applied to distinguish 3 from the primary product, ketenimine 5 (Scheme 2), which apparently undergoes further transformations to produce the 2H-pyran-2-one ring system under the given reaction conditions. Thus, the IR spectra of the isolated products showed strong NH stretching bands at ca. 3225^3210 cm À1 for alkylamino groups. Further evidence was obtained from proton couple 13 C NMR spectra which showed no methine carbon resonance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.